NCT03590496View on ClinicalTrials.gov

Safety and Efficacy of Propionate for Reduction of LDL Cholesterol

NACompletedINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

July 25, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

June 30, 2020

Conditions
Hypercholesterolemia
Interventions
DIETARY_SUPPLEMENT

Calcium-Propionate 500mg

Calcium-Propionate capsules

OTHER

Placebo

Placebo capsules without any active ingredient

Trial Locations (1)

12203

Charité Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT03590496 - Safety and Efficacy of Propionate for Reduction of LDL Cholesterol | Biotech Hunter | Biotech Hunter